Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Paul Freeman OD, FAAO, FOVDR
Paul B. Freeman OD, FAAO, FOVDR Editor-in-Chief
Robert Kleinstein OD, MPH, PhD
Robert N. Kleinstein OD, MPH, PhD Advisory Board
Weiye Li MD, PhD
Weiye Li MD, PhD Advisory Board
See All Experts
Published in Eye Care

News · October 28, 2024

AAO 2024: Latanoprostene Bunod Reduces Intraocular Pressure in Patients With Open-Angle Glaucoma, Ocular Hypertension

Overall, 33% to 46% of patients had ≥20% intraocular pressure reduction ≥20% after switching to latanoprostene bunod

PracticeUpdate Editorial Team

 

 Save  Recommend
 Share

Further Reading

Most Read This Week

Recently Updated